Company

Axoltis Pharma

Biotechnology Research Lyon, Rhône, Fr 14 employees

Employees: 14
Contacts: 2
Emails: 2
Phones: 1

axoltis.com LinkedIn

Axoltis Pharma Overview

Headquarters: Lyon, Rhône, Fr
Website: axoltis.com
Industry: Biotechnology Research
Employees: 14
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

neurodegenerative diseases neurodegeneration spinal cord injury peptide neuroprotection neural repair regeneration drug biotechnology pharma CNS neurology

About Axoltis Pharma

Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.

Axoltis Pharma Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage
Phone contacts: 1; 33.3% coverage

Axoltis Pharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Gilles Avenard	CEO Gabc	Greater Paris Metropolitan Region, France	Email Phone
Yann Godfrin, Ph.d.		Greater Lyon Area, France	Email
Nicolas Rebergue, Phd	Preclinical R&D Project Manager		View